The ‘Pre-eclampsia testing: where are we now?’ symposium was held on Tuesday 11 October.
During this virtual event we discussed the latest guidance on PIGF-based testing from NICE (DG49 formally DG23) and how this could impact clinical practice. Discussions were chaired by Professor Jenny Myers, Professor of Obstetrics & Maternal Medicine Consultant Obstetrician at Maternal & Fetal Health Research Centre, University of Manchester.
The objective is simple; engage with other clinicians to create partnerships in the pre-eclampsia and pregnancy care community.
NICE DG49 update and what it's really like to use the “Ratio” test - Professor Jenny Myers – Professor of Obstetrics & Maternal Medicine Consultant Obstetrician at Maternal & Fetal Health Research Centre, University of Manchester.
Medtech Funding Mandate and pre-eclampsia - Sarah Tyers – MedTech Funding Mandate policy lead, Innovation Research and Life Sciences, NHS England.
First-trimester screening for pre-eclampsia using PIGF - Professor Ranjit Akolekar – Consultant in Fetal Medicine and Obstetrics at Medway NHS Foundation Trust.